SCHEMBL17431200

SCHEMBL17431200

c1ccc2c(c1)oc1c3c(ccc12)-c1ccc2c(oc4ccccc42)c1-c1cc2c(cc1-c1cc4sc5ccccc5c4cc1-3)sc1ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ ALOX5 P09917 3/20 0.39
▸ POLB P06746 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ GPR3 P46089 1/20 0.38
▸ AHR P35869 3/20 0.37
▸ ESR2 Q92731 2/20 0.35
▸ PGR P06401 1/20 0.35
▸ CDC25A P30304 1/20 0.33
▸ CDC25B P30305 1/20 0.33
▸ CDC25C P30307 1/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ DYRK1A Q13627 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17431199 1.00 MAPT (0.40) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17431195 0.82 GPR3 (0.39) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17431204 0.82 GPR3 (0.39) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17431188 0.81 AHR (0.47) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17431203 0.81 AHR (0.47) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17433186 0.81 AHR (0.47) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17431198 0.79 ESR2 (0.40) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17431206 0.78 ALOX5 (0.40) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17431196 0.77 AHR (0.41) MAPTALDH1A1HPGDRAB9ASMN1; SMN2
SCHEMBL17431190 0.77 AHR (0.41) MAPTALDH1A1HPGDRAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10566546-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-02-18 — — US disclosed
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-14 — — US disclosed
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160013422-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, NR4A3, OXSR1 MAPT 4272/4885ALDH1A1 2467/4885HPGD 2811/4885
US-10566546-B2 Organic electroluminescent materials and devices OXER1, NR4A3, OXSR1 MAPT 4272/4885ALDH1A1 2467/4885HPGD 2811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback